Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhance Study: A Prospective, Multicenter Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features

NCT05131139 is registered in ClinicalTrials.gov with Senseonics, Inc. as lead sponsor.

NCT NCT05131139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05131139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhance Study: A Prospective, Multicenter Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features
Lead sponsor
Senseonics, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
October 20, 2021
Completion date
September 30, 2025
Enrollment
350 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, diabetes mellitus, type 1, diabetes mellitus, type 2